CD166 Mesenchymal marker characterizes ADMPC for Periodontal transplant.

Ancell CD166/FITC used as a Mesenchymal marker to characterize Adipose Tissue-Derived Multilineage Progenitor cells (ADMPC) used for Periodontal transplant. The results of this study suggest tha autologous ADMPC transplantation may be a good option for treatment of severe periodontitis.

“Periodontal Regeneration by Allogeneic Transplantation of Adipose Tissue Derived Multi-Lineage Progenitor Stem Cells in vivo.“ M Takedachi, S Murakami, et al. (2022) Scientific Reports 12: 8126 PMID: 35581234

Ancell Mesenchymal Human Antibodies

anti-CD166

anti-CD105